DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Roifman CM, Schroeder H, Berger M et al.
Comparison of the efficacy of IGIV-C, 10% (caprylate/chromatography) and IGIV-SD, 10% as replacement therapy in primary immune deficiency. A randomized double-blind trial.
Int Immunopharmacol 2003;
3: 1325-1333
We do not assume any responsibility for the contents of the web pages of other providers.